Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00646)

• DIG Name: Poloxamer 407
• DIG Function: Emulsifying agent; Solubilizing agent; Surfactant

Full List of Drug(s) Co-administrated with This DIG

14 Approved Drug(s) Co-administrated with This DIG

Drug Name	Drug ID	Indication	Formulation Name	Formulation ID
Acitretin	DM8BKU9	Psoriasis vulgaris [EA90]	Acitretin 10 mg capsule	F00486
Aprepitant	DM053KT	Depression [6A70-6A7Z]	Aprepitant 125 mg capsule	F01373
Dronedarone	DMA8FS5	Angina pectoris [BA40]	Dronedarone Hydrochloride eq 400mg base tablet	F23331
Duloxetine	DM9BI7M	Depression [6A70-6A7Z]	Duloxetine 60 mg capsule	F07131
Famciclovir	DMJHLSD	Meniere disease [AB31.0]	Famciclovir 125 mg tablet	F07843
Fenofibrate	DMFKXDY	Coronary atherosclerosis []	Fenofibrate 48 mg tablet	F08033
Gabapentin	DM6T924	Complex partial seizure [8A68.0]	Gabapentin 600 mg tablet	F08929
Halobetasol Propionate	DM3GB6S	Inflammation [1A00-CA43.1]	Halobetasol Propionate 0.05% lotion	F23768
Methylnaltrexone bromide	DMZTGN2	Opioid-induced constipation [DB32.1]	Methylnaltrexone Bromide 150mg tablet	F23817
Omeprazole	DM471KJ	Cystic fibrosis [CA25]	Omeprazole 20 mg capsule	F15866
Pexidartinib	DMS2J0Z	Tenosynovial giant cell tumour [2F7B]	Pexidartinib 200 mg capsule	F23256
Raloxifene	DMDKF3M	Osteoporosis [FB83.0]	Raloxifene 60 mg tablet	F18685
Raltegravir	DMYURI6	Human immunodeficiency virus infection [1C62]	Raltegravir 400 mg tablet	F18693
Repaglinide	DM5SXUV	Diabetic complication [5A2Y]	Repaglinide 1 mg tablet	F18905